Incyte Corp (INCY)
70.35
-0.70
(-0.99%)
USD |
NASDAQ |
Nov 21, 16:00
70.35
0.00 (0.00%)
After-Hours: 19:38
Incyte Price to Book Value: 4.274 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.316 |
| November 19, 2024 | 4.286 |
| November 18, 2024 | 4.676 |
| November 15, 2024 | 4.609 |
| November 14, 2024 | 4.722 |
| November 13, 2024 | 4.889 |
| November 12, 2024 | 4.895 |
| November 11, 2024 | 4.953 |
| November 08, 2024 | 5.065 |
| November 07, 2024 | 5.002 |
| November 06, 2024 | 4.918 |
| November 05, 2024 | 4.695 |
| November 04, 2024 | 4.602 |
| November 01, 2024 | 4.625 |
| October 31, 2024 | 4.503 |
| October 30, 2024 | 4.491 |
| October 29, 2024 | 4.471 |
| October 28, 2024 | 3.991 |
| October 25, 2024 | 3.953 |
| October 24, 2024 | 3.963 |
| October 23, 2024 | 3.959 |
| October 22, 2024 | 3.985 |
| October 21, 2024 | 3.968 |
| October 18, 2024 | 4.036 |
| October 17, 2024 | 4.039 |
| Date | Value |
|---|---|
| October 16, 2024 | 4.023 |
| October 15, 2024 | 4.030 |
| October 14, 2024 | 3.978 |
| October 11, 2024 | 4.020 |
| October 10, 2024 | 3.974 |
| October 09, 2024 | 3.998 |
| October 08, 2024 | 3.997 |
| October 07, 2024 | 3.998 |
| October 04, 2024 | 4.103 |
| October 03, 2024 | 4.076 |
| October 02, 2024 | 4.112 |
| October 01, 2024 | 4.138 |
| September 30, 2024 | 4.019 |
| September 27, 2024 | 4.230 |
| September 26, 2024 | 4.185 |
| September 25, 2024 | 4.063 |
| September 24, 2024 | 4.094 |
| September 23, 2024 | 4.120 |
| September 20, 2024 | 4.225 |
| September 19, 2024 | 4.294 |
| September 18, 2024 | 4.188 |
| September 17, 2024 | 4.269 |
| September 16, 2024 | 4.268 |
| September 13, 2024 | 4.084 |
| September 12, 2024 | 4.072 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.130
Minimum
Apr 25 2024
12.22
Maximum
Jun 22 2020
5.145
Average
4.336
Median
Price to Book Value Benchmarks
| Pfizer Inc | 1.543 |
| Biomarin Pharmaceutical Inc | 2.233 |
| Syndax Pharmaceuticals Inc | 3.632 |
| Allogene Therapeutics Inc | 0.9540 |
| Arcutis Biotherapeutics Inc | 7.652 |
Price to Book Value Related Metrics
| PE Ratio | 502.50 |
| PS Ratio | 3.744 |
| Price to Free Cash Flow | 908.24 |
| Price | 70.35 |
| Earnings Yield | 0.20% |
| Market Cap | 13.55B |
| Operating PE Ratio | 2512.39 |